Maintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept. [electronic resource]
- Clinical drug investigation Jul 2019
- 595-606 p. digital
Publication Type: Journal Article; Review
1179-1918
10.1007/s40261-019-00790-9 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use Bevacizumab--administration & dosage Breast Neoplasms--drug therapy Capecitabine--administration & dosage Female Humans Prognosis Quality of Life Receptor, ErbB-2--metabolism Remission Induction Retrospective Studies